| Emmanuel C Anekwe, MD | |
|
7500 N Mesa St Ste 210, El Paso, TX 79912-3515 | |
| (915) 307-7800 | |
| (915) 351-4001 |
| Full Name | Emmanuel C Anekwe |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 28 Years |
| Location | 7500 N Mesa St Ste 210, El Paso, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205871720 | NPI | - | NPPES |
| 201307006 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | N1530 (Texas) | Primary |
| 207R00000X | Internal Medicine | N1530 (Texas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Hospitals Of Providence Transmountain Campus | El paso, TX | Hospital |
| Las Palmas Medical Center | El paso, TX | Hospital |
| The Hospitals Of Providence - East Campus | El paso, TX | Hospital |
| Mountain View Regional Medical Center | Las cruces, NM | Hospital |
| Memorial Medical Center | Las cruces, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| A And V Doctors Pllc | 3476873571 | 7 |
| A And V Doctors Pllc | 3476873571 | 7 |
News Archive
A collaboration between stroke neurologists at the Medical University of South Carolina and bioengineers at the University of Massachusetts has led to the creation of a realistic, 3D-printed phantom of a stenotic intracranial artery that is being used to standardize protocols for high-resolution MRI, also known as vessel-wall MRI, at a network of U.S. and Chinese institutions, according to an article published online March 9, 2017 by the Journal of NeuroInterventional Surgery.
Researchers have developed the first global model for predicting cardiovascular disease (CVD) risk. The model—developed by Harvard T.H. Chan School of Public Health, Imperial College London, and colleagues—will be of particular help to public health professionals, clinicians, and patients in developing countries for prevention of CVD.
Scientists in the United States have found that stem cell transplants enabled people with type 1 diabetes to manage for as long as four years without needing insulin injections and to maintain good glycemic control - such patients typically need daily insulin therapy to control their diabetes.
Building upon a series of successful preclinical studies, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody they developed that can neutralize the Hepatitis C virus (HCV).
› Verified 8 days ago
| Entity Name | Brazos Vascular Access Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982955175 PECOS PAC ID: 9032361225 Enrollment ID: O20121217000108 |
News Archive
A collaboration between stroke neurologists at the Medical University of South Carolina and bioengineers at the University of Massachusetts has led to the creation of a realistic, 3D-printed phantom of a stenotic intracranial artery that is being used to standardize protocols for high-resolution MRI, also known as vessel-wall MRI, at a network of U.S. and Chinese institutions, according to an article published online March 9, 2017 by the Journal of NeuroInterventional Surgery.
Researchers have developed the first global model for predicting cardiovascular disease (CVD) risk. The model—developed by Harvard T.H. Chan School of Public Health, Imperial College London, and colleagues—will be of particular help to public health professionals, clinicians, and patients in developing countries for prevention of CVD.
Scientists in the United States have found that stem cell transplants enabled people with type 1 diabetes to manage for as long as four years without needing insulin injections and to maintain good glycemic control - such patients typically need daily insulin therapy to control their diabetes.
Building upon a series of successful preclinical studies, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody they developed that can neutralize the Hepatitis C virus (HCV).
› Verified 8 days ago
| Entity Name | A & V Doctors Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700274149 PECOS PAC ID: 3476873571 Enrollment ID: O20150513000499 |
News Archive
A collaboration between stroke neurologists at the Medical University of South Carolina and bioengineers at the University of Massachusetts has led to the creation of a realistic, 3D-printed phantom of a stenotic intracranial artery that is being used to standardize protocols for high-resolution MRI, also known as vessel-wall MRI, at a network of U.S. and Chinese institutions, according to an article published online March 9, 2017 by the Journal of NeuroInterventional Surgery.
Researchers have developed the first global model for predicting cardiovascular disease (CVD) risk. The model—developed by Harvard T.H. Chan School of Public Health, Imperial College London, and colleagues—will be of particular help to public health professionals, clinicians, and patients in developing countries for prevention of CVD.
Scientists in the United States have found that stem cell transplants enabled people with type 1 diabetes to manage for as long as four years without needing insulin injections and to maintain good glycemic control - such patients typically need daily insulin therapy to control their diabetes.
Building upon a series of successful preclinical studies, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody they developed that can neutralize the Hepatitis C virus (HCV).
› Verified 8 days ago
| Entity Name | Medimount Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932807864 PECOS PAC ID: 3173986924 Enrollment ID: O20230828002816 |
News Archive
A collaboration between stroke neurologists at the Medical University of South Carolina and bioengineers at the University of Massachusetts has led to the creation of a realistic, 3D-printed phantom of a stenotic intracranial artery that is being used to standardize protocols for high-resolution MRI, also known as vessel-wall MRI, at a network of U.S. and Chinese institutions, according to an article published online March 9, 2017 by the Journal of NeuroInterventional Surgery.
Researchers have developed the first global model for predicting cardiovascular disease (CVD) risk. The model—developed by Harvard T.H. Chan School of Public Health, Imperial College London, and colleagues—will be of particular help to public health professionals, clinicians, and patients in developing countries for prevention of CVD.
Scientists in the United States have found that stem cell transplants enabled people with type 1 diabetes to manage for as long as four years without needing insulin injections and to maintain good glycemic control - such patients typically need daily insulin therapy to control their diabetes.
Building upon a series of successful preclinical studies, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody they developed that can neutralize the Hepatitis C virus (HCV).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emmanuel C Anekwe, MD Po Box 221408, El Paso, TX 79913-4408 Ph: (915) 307-7800 | Emmanuel C Anekwe, MD 7500 N Mesa St Ste 210, El Paso, TX 79912-3515 Ph: (915) 307-7800 |
News Archive
A collaboration between stroke neurologists at the Medical University of South Carolina and bioengineers at the University of Massachusetts has led to the creation of a realistic, 3D-printed phantom of a stenotic intracranial artery that is being used to standardize protocols for high-resolution MRI, also known as vessel-wall MRI, at a network of U.S. and Chinese institutions, according to an article published online March 9, 2017 by the Journal of NeuroInterventional Surgery.
Researchers have developed the first global model for predicting cardiovascular disease (CVD) risk. The model—developed by Harvard T.H. Chan School of Public Health, Imperial College London, and colleagues—will be of particular help to public health professionals, clinicians, and patients in developing countries for prevention of CVD.
Scientists in the United States have found that stem cell transplants enabled people with type 1 diabetes to manage for as long as four years without needing insulin injections and to maintain good glycemic control - such patients typically need daily insulin therapy to control their diabetes.
Building upon a series of successful preclinical studies, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody they developed that can neutralize the Hepatitis C virus (HCV).
› Verified 8 days ago
Sara Alhariri, Nephrology Medicare: Medicare Enrolled Practice Location: 4801 Alberta Ave, El Paso, TX 79905 Phone: 912-215-8000 | |
Dr. Ney Mckinley Gore Iii, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 5005 N Piedras St, William Beaumont Army Medical Center, El Paso, TX 79920 Phone: 915-569-1382 Fax: 915-569-1233 | |
Armando D. Meza, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4801 Alberta Ave., 4801 Alberta Ave, El Paso, TX 79905 Phone: 915-545-6647 Fax: 915-545-9799 | |
Carlos E. Rodriguez Castro, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4800 Alberta Ave, El Paso, TX 79905 Phone: 915-545-6626 | |
Dr. Pratik Naik, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5005 N Piedras St, El Paso, TX 79920 Phone: 915-742-2180 Fax: 915-742-1919 | |
Alejandro Robles, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 4801 Alberta Ave, El Paso, TX 79905 Phone: 915-215-5200 Fax: 915-215-8640 | |
Dr. Rey Francisco Rosario, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1250 E Cliff Dr, Suite 3e, El Paso, TX 79902 Phone: 915-626-5548 Fax: 915-626-5411 |